AKR1B10 expression in benign prostatic hyperplasia and its related mechanism

The aim of the present study was to investigate the expression of aldo-keto reductase family 1 member B10 (AKR1B10) in benign prostatic hyperplasia (BPH) and its related mechanism. In total, 142 BPH patients admitted from March 2017 to March 2019 at the First Hospital of Hunan University of Chinese...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wenjing, Gao, Ya, Zhang, Jiaqi, Zhang, Rong, Chen, Qihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335732/
https://www.ncbi.nlm.nih.gov/pubmed/34434282
http://dx.doi.org/10.3892/ol.2021.12944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335732/
https://www.ncbi.nlm.nih.gov/pubmed/34434282
http://dx.doi.org/10.3892/ol.2021.12944

Ejemplares similares